一个差异向的核心外微针贴片,具有协调和长时间释放的曼吉费林和MSC衍生的外体,用于无痕皮肤再生
Shang Lyu1,2,3, Qi Liu1,2, Ho-Yin Yuen1,2
1Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hung Hom, Hong Kong SAR 999077, China.
Materials horizons
|April 26, 2024
概括
这项研究引入了一种新的核心外微针贴片,用于无痕皮肤修复. 微针可以提供可控的双药释放,以减少炎症并促进再生.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 皮肤病学 皮肤病学
背景情况:
- 传统的微针在控制药物释放,药物多样性和伤口粘附方面面临着挑战.
- 痕仍然是皮肤修复的一个重要问题,需要先进的治疗策略.
研究的目的:
- 开发一种新的核心外微针贴片,用于无痕的皮肤再生.
- 为了实现差异化和延长的抗炎剂和外体的释放,以改善伤口愈合.
主要方法:
- 使用水友性凝甲基 (GelMA) 和水友性多 (lactide-co-propylene glycol-co-lactide) 二甲基酸盐 (PGLADMA) 制造一个核心外微针.
- 装载GelMA外含有曼吉费林和PGLADMA核心,其中包含来自人类介质细胞 stromal细胞 (hMSCs) 的外体.
- 在体外和体外对抗炎性质,血管新生诱导和痕形成减少的评估.
主要成果:
- 核心外微针证明了曼吉费林和外体的受控释放,在3周内释放了30%的外体.
- 观察到显著的抗炎作用,包括调节的巨细胞两极分化和减少体内炎症.
- 微针在体外 (HUVEC管形成) 和体内 (血管形成) 促进了血管生成,并增强了再表皮化.
- 在体内观察到减少痕形成,这表明无痕皮肤修复的潜力.
结论:
- 开发的核心外微针贴片使治疗剂的分化和持续释放成为可能,以改善皮肤再生.
- 这种创新设计通过结合抗炎和益血管效应,促进无伤痕愈合.
- 微针平台对各种再生医学应用具有前景,这些应用需要长期输送像外体体这样的生物活性分子.
相关概念视频
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:12Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K